RBC Bearings Total Revenue increased by 12.2% to $518.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.3%, from $437.70M to $518.00M. Over 4 years (FY 2022 to FY 2026), Total Revenue shows an upward trend with a 18.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenue| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $156.21M | $160.90M | $266.95M | $358.84M | $354.10M | $369.20M | $351.60M | $394.40M | $387.10M | $385.60M | $373.90M | $413.70M | $406.30M | $397.90M | $394.40M | $437.70M | $436.00M | $455.30M | $461.60M | $518.00M |
| QoQ Change | — | +3.0% | +65.9% | +34.4% | -1.3% | +4.3% | -4.8% | +12.2% | -1.9% | -0.4% | -3.0% | +10.6% | -1.8% | -2.1% | -0.9% | +11.0% | -0.4% | +4.4% | +1.4% | +12.2% |
| YoY Change | — | — | — | — | +126.7% | +129.5% | +31.7% | +9.9% | +9.3% | +4.4% | +6.3% | +4.9% | +5.0% | +3.2% | +5.5% | +5.8% | +7.3% | +14.4% | +17.0% | +18.3% |
| Segment | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Industrial | $271.30M | $257.20M | $254.70M | $251.20M | $280.40M | $271.40M | $256.50M | $259.10M |
| Aerospace Defense | $142.40M | $149.10M | $143.20M | $143.20M | $157.30M | $164.60M | $198.80M | $202.50M |
| Total | $413.70M | $406.30M | $397.90M | $394.40M | $437.70M | $436.00M | $455.30M | $461.60M |
| Segment | Q1 '22 | Q1 '23 | Q4 '23 |
|---|---|---|---|
| Domestic | — | $208.35M | $208.35M |
| Industrial | $75.31M | $140.37M | $140.37M |
| Aerospace Defense | $99.06M | $95.37M | $95.37M |
| Foreign | — | $27.38M | $27.38M |
| Total | $156.21M | $354.10M | $394.40M |
Aerospace Defense, Domestic, Foreign are derived from annual filings.
Aerospace Defense, Domestic, Foreign, Industrial were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 |
|---|---|---|---|---|
| US | $329.00M | $363.10M | $360.10M | $352.40M |
| Total | $373.90M | $413.70M | $406.30M | $397.90M |
| Segment | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| International | $44.90M | $50.60M | $46.20M | $45.50M | $45.50M | $49.40M | $47.50M | $49.10M |
| Total | $373.90M | $413.70M | $406.30M | $397.90M | $394.40M | $437.70M | $436.00M | $455.30M |
International was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.